ESPERION THERAPEUTICS INC (ESPR)

US29664W1053 - Common Stock

2.08  +0.02 (+0.97%)

After market: 2.08 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
116.33M75.50M78.40M227.50M148.40M
Cost Of Goods
43.27M27.00M14.20M2.40MN/A
Gross Profit
73.07M48.50M64.20M225.20MN/A
Operating Expenses
228.63M228.00M277.70M346.50M241.50M
Research and Development
86.11M118.90M106.00M146.90M175.60M
Selling, General, and Administrative Expenses
142.52M109.10M171.70M199.60M65.90M
Operating Income
-155.56M-179.50M-213.40M-121.40M-93.10M
Interest Income/Expense
-54.58M-54.40M-46.30M-22.20M-4.40M
Other Income/Expense
891.00K300.00K3.90M0.00400.00K
Non Recurring Items
N/AN/A-13.30MN/AN/A
Income Before Taxes
-209.25M-233.70M-269.10M-143.60M-97.20M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-209.25M-233.70M-269.10M-143.60M-97.20M
EBITDA
-155.40M-179.00M-212.79M-120.85M-92.78M
 
Per Share Data
EPS Diluted Total Ops
-2.03-3.52-9.31-5.23-3.59
Non GAAP EPS
-2.12-3.55-9.56-5.48-3.72
 
Statistics
Gross Profit Margin
62.81%64.24%81.89%98.99%N/A
Profit Margin
-179.87%-309.54%-343.24%-63.12%-65.50%
Operating Profit Margin
-133.72%-237.75%-272.19%-53.36%-62.74%

All data in USD

Charts